Forty Seven Inc.

FTSV:NASDAQ

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Forty Seven is a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer. Forty Seven focus its efforts on targeting the CD47 pathway as a way to engage macrophages in fighting tumors.